https://www.europesays.com/ch/142711/ Novartis advances multiple sclerosis innovation with late-breaking remibrutinib and broad portfolio data at MSToronto2026 #401k #business #BusinessNews #Economy #finance #FinancialInformation #Investing #InvestmentTools #Investor #MarketNews #mortgage #MutualFunds #Novartis #PersonalFinance #quote #RealEstate #retirement #stock #StockResearch #StockValuation #stocks #SuzeOrman #tax #TrackPortfolio
#novartis — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #novartis, aggregated by home.social.
-
https://www.europesays.com/unitedstates/25812/ U.S. futures advance as earnings from major companies improve investor sentiment: Dow Jones, S&P, Nasdaq, Wall Street #CorporateEarnings #EarningsCalendar #EquityFutures #GeneralMotors #investors #Novartis #OilFutures #PreMarketTrading #QuarterlyEarnings #WallStreet #WallStreetBull
-
https://www.europesays.com/ch/142216/ Muscular dystrophy therapy is available, but only to a fortunate few #biotechnology #ClinicalTrials #DrugDevelopment #genetics #Novartis #RareDiseases #STAT+
-
https://www.europesays.com/ch/142184/ Novartis Rhapsido® (remibrutinib) receives FDA approval as #ChronicIllness #Innovation #MediaRelease #Novartis #NovartisPharmaAG #ReimagineMedicine #SwissStockExchange:NOVNSW
-
https://www.europesays.com/ch/142174/ NVS Wins FDA Nod for Label Expansion of Immunology Drug Rhapsido #futures #IndexMarketQuote #IndexMarketQuotes #IndexMarketSymbol #IndexMarketSymbols #indices #Novartis #NovartisAgADR #NVS #TheGlobeAndMail
-
https://www.europesays.com/ch/141869/ Novartis signs $7.8B mRNA deal with Chinese biotech #AbogenBiosciences #AutoimmuneDiseases #DrugDevelopment #EastHanover #LicensingAgreement #mRNA #Novartis #PharmaceuticalIndustry
-
https://www.europesays.com/ch/141741/ FDA Greenslights Novartis’s Rhapsido as First Treatment for Chronic Friction Hives #Novartis